Discover the latest breakthroughs in myeloma treatment from EHA 2024, as Dr. Ola Landgren discusses the efficacy of bispecific antibodies and the role of precision medicine in managing this complex disease. Gain insights into treatment sequencing, side effects, and biomarkers shaping the future of patient care.
The HealthTree Foundation for Multiple Myeloma brings information from the experts to the patients! Learn more at www.healthtree...
Donate to the HealthTree Foundation for Multiple Myeloma or learn more about additional myeloma support we offer here: give.healthtre...
HealthTree Cure Hub helps you find your best treatment options and accelerate a cure for multiple myeloma. Join today at www.healthtree...
Follow HealthTree:
twitter.com/healthtreeformm
facebook.com/healthtreeformultiplemyeloma
instragram.com/healthtreeformultiplemyeloma
Негізгі бет Bispecific Antibodies and Precision Medicine Insights on Myeloma Px | Ola Landgren, MD | EHA 2024
Пікірлер: 2